Global Orphan Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • ID:PD032391
  • September 2020
  • GIR (Global Info Research)
                          

The Global Orphan Drugs Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2020 to 2025. The detailed sales channel is also covered in the study.

The global Orphan Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.3% in the forecast period of 2020 to 2025 and will expected to reach USD 167980 million by 2025, from USD 117860 million in 2019.

The Orphan Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market Segmentation
Orphan Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Orphan Drugs market has been segmented into

  •     Oncology
  •     Gastrointestinal
  •     Pulmonary
  •     Neurology
  •     Hematology
  •     Cardio-vascular
  •     Metabolic disorders
  •     Endocrinology
  •     Infectious diseases
  •     Others

By Application, Orphan Drugs has been segmented into:
  •     Hospital Pharmacies
  •     Speciality Pharmacies
  •     Retail pharmacies
  •     Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Orphan Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Orphan Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Orphan Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Orphan Drugs market in important countries (regions), including:
  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, France, UK, Russia and Italy)
  •     Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  •     South America (Brazil, Argentina, etc.)
  •     Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Orphan Drugs Market Share Analysis
Orphan Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Orphan Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Orphan Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Orphan Drugs are:
  •     Novartis AG
  •     Eli Lilly and Company
  •     F. Hoffmann-La Roche Ltd.
  •     Bristol-Myers Squibb Company
  •     Alexion Pharmaceuticals, Inc.
  •     Celgene Corporation
  •     AstraZeneca
  •     Sanofi S.A.
  •     Pfizer, Inc.
  •     Novo Nordisk A/S
  •     Merck & Co., Inc.
  •     Takeda
  •     Eisai Co., Ltd.
  •     Johnson & Johnson
  •     GlaxoSmithKline
  •     Daiichi Sankyo Company Limited
  •     Amgen, Inc.
  •     Biogen, Inc.
  •     Bayer AG

Among other players domestic and global, Orphan Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orphan Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orphan Drugs, with price, sales, revenue and global market share of Orphan Drugs in 2018 and 2019.
Chapter 3, the Orphan Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orphan Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Orphan Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Orphan Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Orphan Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Orphan Drugs Revenue by Type
        1.2.2 Oncology
        1.2.3 Gastrointestinal
        1.2.4 Pulmonary
        1.2.5 Neurology
        1.2.6 Hematology
        1.2.7 Cardio-vascular
        1.2.8 Metabolic disorders
        1.2.9 Endocrinology
        1.2.10 Infectious diseases
        1.2.11 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Orphan Drugs Revenue by Application
        1.3.2 Hospital Pharmacies
        1.3.3 Speciality Pharmacies
        1.3.4 Retail pharmacies
        1.3.5 Others
    1.4 Overview of Global Orphan Drugs Market
        1.4.1 Global Orphan Drugs Market Status and Outlook (2015-2025)
        1.4.2 North America (United States, Canada and Mexico)
        1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
        1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        1.4.5 South America, Middle East & Africa
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Novartis AG
        2.1.1 Novartis AG Details
        2.1.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
        2.1.3 Novartis AG SWOT Analysis
        2.1.4 Novartis AG Product and Services
        2.1.5 Novartis AG Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.2 Eli Lilly and Company
        2.2.1 Eli Lilly and Company Details
        2.2.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
        2.2.3 Eli Lilly and Company SWOT Analysis
        2.2.4 Eli Lilly and Company Product and Services
        2.2.5 Eli Lilly and Company Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.3 F. Hoffmann-La Roche Ltd.
        2.3.1 F. Hoffmann-La Roche Ltd. Details
        2.3.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
        2.3.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
        2.3.4 F. Hoffmann-La Roche Ltd. Product and Services
        2.3.5 F. Hoffmann-La Roche Ltd. Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.4 Bristol-Myers Squibb Company
        2.4.1 Bristol-Myers Squibb Company Details
        2.4.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
        2.4.3 Bristol-Myers Squibb Company SWOT Analysis
        2.4.4 Bristol-Myers Squibb Company Product and Services
        2.4.5 Bristol-Myers Squibb Company Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.5 Alexion Pharmaceuticals, Inc.
        2.5.1 Alexion Pharmaceuticals, Inc. Details
        2.5.2 Alexion Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
        2.5.3 Alexion Pharmaceuticals, Inc. SWOT Analysis
        2.5.4 Alexion Pharmaceuticals, Inc. Product and Services
        2.5.5 Alexion Pharmaceuticals, Inc. Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.6 Celgene Corporation
        2.6.1 Celgene Corporation Details
        2.6.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
        2.6.3 Celgene Corporation SWOT Analysis
        2.6.4 Celgene Corporation Product and Services
        2.6.5 Celgene Corporation Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.7 AstraZeneca
        2.7.1 AstraZeneca Details
        2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
        2.7.3 AstraZeneca SWOT Analysis
        2.7.4 AstraZeneca Product and Services
        2.7.5 AstraZeneca Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.8 Sanofi S.A.
        2.8.1 Sanofi S.A. Details
        2.8.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis
        2.8.3 Sanofi S.A. SWOT Analysis
        2.8.4 Sanofi S.A. Product and Services
        2.8.5 Sanofi S.A. Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.9 Pfizer, Inc.
        2.9.1 Pfizer, Inc. Details
        2.9.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
        2.9.3 Pfizer, Inc. SWOT Analysis
        2.9.4 Pfizer, Inc. Product and Services
        2.9.5 Pfizer, Inc. Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.10 Novo Nordisk A/S
        2.10.1 Novo Nordisk A/S Details
        2.10.2 Novo Nordisk A/S Major Business and Total Revenue (Financial Highlights) Analysis
        2.10.3 Novo Nordisk A/S SWOT Analysis
        2.10.4 Novo Nordisk A/S Product and Services
        2.10.5 Novo Nordisk A/S Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.11 Merck & Co., Inc.
        2.11.1 Merck & Co., Inc. Details
        2.11.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
        2.11.3 Merck & Co., Inc. SWOT Analysis
        2.11.4 Merck & Co., Inc. Product and Services
        2.11.5 Merck & Co., Inc. Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.12 Takeda
        2.12.1 Takeda Details
        2.12.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
        2.12.3 Takeda SWOT Analysis
        2.12.4 Takeda Product and Services
        2.12.5 Takeda Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.13 Eisai Co., Ltd.
        2.13.1 Eisai Co., Ltd. Details
        2.13.2 Eisai Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
        2.13.3 Eisai Co., Ltd. SWOT Analysis
        2.13.4 Eisai Co., Ltd. Product and Services
        2.13.5 Eisai Co., Ltd. Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.14 Johnson & Johnson
        2.14.1 Johnson & Johnson Details
        2.14.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
        2.14.3 Johnson & Johnson SWOT Analysis
        2.14.4 Johnson & Johnson Product and Services
        2.14.5 Johnson & Johnson Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.15 GlaxoSmithKline
        2.15.1 GlaxoSmithKline Details
        2.15.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
        2.15.3 GlaxoSmithKline SWOT Analysis
        2.15.4 GlaxoSmithKline Product and Services
        2.15.5 GlaxoSmithKline Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.16 Daiichi Sankyo Company Limited
        2.16.1 Daiichi Sankyo Company Limited Details
        2.16.2 Daiichi Sankyo Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
        2.16.3 Daiichi Sankyo Company Limited SWOT Analysis
        2.16.4 Daiichi Sankyo Company Limited Product and Services
        2.16.5 Daiichi Sankyo Company Limited Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.17 Amgen, Inc.
        2.17.1 Amgen, Inc. Details
        2.17.2 Amgen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
        2.17.3 Amgen, Inc. SWOT Analysis
        2.17.4 Amgen, Inc. Product and Services
        2.17.5 Amgen, Inc. Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.18 Biogen, Inc.
        2.18.1 Biogen, Inc. Details
        2.18.2 Biogen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
        2.18.3 Biogen, Inc. SWOT Analysis
        2.18.4 Biogen, Inc. Product and Services
        2.18.5 Biogen, Inc. Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    2.19 Bayer AG
        2.19.1 Bayer AG Details
        2.19.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
        2.19.3 Bayer AG SWOT Analysis
        2.19.4 Bayer AG Product and Services
        2.19.5 Bayer AG Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
    3.1 Global Orphan Drugs Sales and Market Share by Manufacturer (2018-2019)
    3.2 Global Orphan Drugs Revenue and Market Share by Manufacturer (2018-2019)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Orphan Drugs Manufacturer Market Share in 2019
        3.3.2 Top 6 Orphan Drugs Manufacturer Market Share in 2019
    3.4 Market Competition Trend
4 Global Market Analysis by Regions
    4.1 Global Orphan Drugs Sales, Revenue and Market Share by Regions
        4.1.1 Global Orphan Drugs Sales and Market Share by Regions (2015-2020)
        4.1.2 Global Orphan Drugs Revenue and Market Share by Regions (2015-2020)
    4.2 North America Orphan Drugs Sales and Growth Rate (2015-2020)
    4.3 Europe Orphan Drugs Sales and Growth Rate (2015-2020)
    4.4 Asia-Pacific Orphan Drugs Sales and Growth Rate (2015-2020)
    4.5 South America Orphan Drugs Sales and Growth Rate (2015-2020)
    4.6 Middle East and Africa Orphan Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
    5.1 North America Orphan Drugs Sales, Revenue and Market Share by Country
        5.1.1 North America Orphan Drugs Sales and Market Share by Country (2015-2020)
        5.1.2 North America Orphan Drugs Revenue and Market Share by Country (2015-2020)
    5.2 United States Orphan Drugs Sales and Growth Rate (2015-2020)
    5.3 Canada Orphan Drugs Sales and Growth Rate (2015-2020)
    5.4 Mexico Orphan Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
    6.1 Europe Orphan Drugs Sales, Revenue and Market Share by Country
        6.1.1 Europe Orphan Drugs Sales and Market Share by Country (2015-2020)
        6.1.2 Europe Orphan Drugs Revenue and Market Share by Country (2015-2020)
    6.2 Germany Orphan Drugs Sales and Growth Rate (2015-2020)
    6.3 UK Orphan Drugs Sales and Growth Rate (2015-2020)
    6.4 France Orphan Drugs Sales and Growth Rate (2015-2020)
    6.5 Russia Orphan Drugs Sales and Growth Rate (2015-2020)
    6.6 Italy Orphan Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
    7.1 Asia-Pacific Orphan Drugs Sales, Revenue and Market Share by Regions
        7.1.1 Asia-Pacific Orphan Drugs Sales and Market Share by Regions (2015-2020)
        7.1.2 Asia-Pacific Orphan Drugs Revenue and Market Share by Regions (2015-2020)
    7.2 China Orphan Drugs Sales and Growth Rate (2015-2020)
    7.3 Japan Orphan Drugs Sales and Growth Rate (2015-2020)
    7.4 Korea Orphan Drugs Sales and Growth Rate (2015-2020)
    7.5 India Orphan Drugs Sales and Growth Rate (2015-2020)
    7.6 Southeast Asia Orphan Drugs Sales and Growth Rate (2015-2020)
    7.7 Australia Orphan Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
    8.1 South America Orphan Drugs Sales, Revenue and Market Share by Country
        8.1.1 South America Orphan Drugs Sales and Market Share by Country (2015-2020)
        8.1.2 South America Orphan Drugs Revenue and Market Share by Country (2015-2020)
    8.2 Brazil Orphan Drugs Sales and Growth Rate (2015-2020)
    8.3 Argentina Orphan Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
    9.1 Middle East & Africa Orphan Drugs Sales, Revenue and Market Share by Country
        9.1.1 Middle East & Africa Orphan Drugs Sales and Market Share by Country (2015-2020)
        9.1.2 Middle East & Africa Orphan Drugs Revenue and Market Share by Country (2015-2020)
    9.2 Saudi Arabia Orphan Drugs Sales and Growth Rate (2015-2020)
    9.3 Turkey Orphan Drugs Sales and Growth Rate (2015-2020)
    9.4 Egypt Orphan Drugs Sales and Growth Rate (2015-2020)
    9.5 South Africa Orphan Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
    10.1 Global Orphan Drugs Sales and Market Share by Type (2015-2020)
    10.2 Global Orphan Drugs Revenue and Market Share by Type (2015-2020)
    10.3 Global Orphan Drugs Price by Type (2015-2020)
11 Global Orphan Drugs Market Segment by Application
    11.1 Global Orphan Drugs Sales Market Share by Application (2015-2020)
    11.2 Global Orphan Drugs Revenue Market Share by Application (2015-2020)
    11.3 Global Orphan Drugs Price by Application (2015-2020)
12 Market Forecast
    12.1 Global Orphan Drugs Sales, Revenue and Growth Rate (2021-2025)
    12.2 Orphan Drugs Market Forecast by Regions (2021-2025)
        12.2.1 North America Orphan Drugs Market Forecast (2021-2025)
        12.2.2 Europe Orphan Drugs Market Forecast (2021-2025)
        12.2.3 Asia-Pacific Orphan Drugs Market Forecast (2021-2025)
        12.2.4 South America Orphan Drugs Market Forecast (2021-2025)
        12.2.5 Middle East & Africa Orphan Drugs Market Forecast (2021-2025)
    12.3 Orphan Drugs Market Forecast by Type (2021-2025)
        12.3.1 Global Orphan Drugs Sales Forecast by Type (2021-2025)
        12.3.2 Global Orphan Drugs Market Share Forecast by Type (2021-2025)
    12.4 Orphan Drugs Market Forecast by Application (2021-2025)
        12.4.1 Global Orphan Drugs Sales Forecast by Application (2021-2025)
        12.4.2 Global Orphan Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source
    15.3 Disclaimer
    15.4 About US

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..